Cardiology Division Head Women's College Hospital University of Toronto
Disclosure(s):
Jacob A. Udell, MD, MPH: Boehringer Ingelheim: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Janssen: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Novovax: Consultant/Advisory Board (Terminated, December 8, 2022); Sanofi: Consultant/Advisory Board (Terminated, May 16, 2022)
Learning Objectives / Objectifs d'apprentissage:
At the end of this session participants will be able to / Au terme de cette conférence, vous serez:
assess how age-related changes in the immune system contribute to the pathophysiology of cardiovascular disease (CVD), diabetes, and susceptibility to severe infections;
explain the relationships between CVD and diabetes and increased risk of clinical complications associated with viral infections including influenza and COVID-19; and
analyze the evidence for immunization as a strategy to reduce the risk of complications from infections and discuss practical considerations for cardiovascular and endocrinology specialists.
This program was co-developed by the Canadian Cardiovascular Society and GSK Canada and was planned to achieve scientific integrity, objectivity, and balance.
Session Description:This symposium is intended for cardiologists, endocrinologists, diabetologists, hematologists, internists, family physicians, residents, and allied health professionals and will focus on the role of immunization in preventing severe outcomes in patients with chronic conditions, such as cardiovascular disease (CVD) and diabetes as these patients are at increased risk of vaccine-preventable disease and severe outcomes following infection. The symposium will explore how age-related changes in the immune system contribute to the pathophysiology of CVD, diabetes, and susceptibility to severe infections, as well as the relationships between CVD, diabetes, and increased risk of clinical complications associated with viral infections, including influenza, COVID-19, respiratory syncytial virus and herpes zoster. The symposium will also shed light on clinical considerations for the management of immunization by cardiovascular and endocrinology specialists caring for patients with diabetes or CVD.
